Roche Diabetes Care, Inc. – FDA 483, Jul 25, 2019
Roche Diabetes Care, Inc. in Indianapolis, IN, was issued a Form FDA 483 following an inspection from July 15-25, 2019, citing three observations. The firm failed to adequately validate a process related to a debris detection system and did not maintain complete supporting data or updated specifications. Significant deficiencies were also noted in corrective and preventive action (CAPA) procedures, including lack of effectiveness verification and numerous overdue tasks. Additionally, process control procedures for cleaning and preventive maintenance were not adequately established.
ID · 8eef2a9f-44ae-49ed-8071-98d08d894d1c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.